SSX5 antibody (Middle Region)
Quick Overview for SSX5 antibody (Middle Region) (ABIN2774973)
Target
See all SSX5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Purpose
- SSX5 Antibody - middle region
-
Sequence
- GRLQGIFPKI TPEKPAEEGN DSKGVPEASG PQNNGKQLRP SGKLNTSEKV
-
Predicted Reactivity
- Human: 100%
-
Characteristics
- This is a rabbit polyclonal antibody against SSX5. It was validated on Western Blot using a cell lysate as a positive control.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human SSX5
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
We also sell a specific blocking peptide that can be used in combination with this antibody. You can find the blocking peptide under AAP35989-100UG
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- prevent freeze-thaw cycles
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
-
- SSX5 (Synovial Sarcoma, X Breakpoint 5 (SSX5))
-
Alternative Name
- SSX5
-
Background
-
Background Information: SSX5 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. The gene encoding SSX5 appears not to be involved in this type of chromosome translocation. The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation. Two transcript variants encoding distinct isoforms have been identified for this gene.
Gene Name: Synovial sarcoma, X breakpoint 5
Alternative Symbols: MGC9494
Protein Name: Protein SSX5
-
Molecular Weight
- 26kDa
-
Gene ID
- 6758
-
NCBI Accession
- NP_066295
-
UniProt
- Q5JQ60
Target
-